AML-DC

Dendritic cells derived from periperal blood or bone marrow-derived AML blasts.
Cell Type:
Dendritic cell (DC)
Tissue Origin:
blood
Species:
human
Research Area:
Immunotherapy / Hematology
Cell Characteristics:
Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
DC, human U-002 2e6 23% ±8 61% ±18 Plasmid (general) 5 µg 100 µl I/II/2b

Citations

Categories:
Transfection 
Authors:
Curti A, Pandolfi S, Aluigi M, Isidori A, Alessandrini I, Chiodoni C, Testoni N, Colombo MP, Baccarani M, Lemoli RM 
In:
Exp Hematol (2005) 33(12): 1521-30